View ValuationCellyan Biotechnology 将来の成長Future 基準チェック /06現在、 Cellyan Biotechnologyの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Logistics 収益成長9.9%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesNew Risk • Apr 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 21% over the past year. Shareholders have been substantially diluted in the past year (114% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (US$16.3m market cap).New Risk • Mar 29New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 114% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 21% over the past year. Shareholders have been substantially diluted in the past year (114% increase in shares outstanding). Minor Risk Market cap is less than US$100m (US$16.0m market cap).New Risk • Mar 19New major risk - Revenue and earnings growthRevenue has declined by 21% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 21% over the past year. Market cap is less than US$10m (US$7.25m market cap).New Risk • Mar 02New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (US$7.26m market cap). Minor Risk Latest financial reports are more than 6 months old (reported March 2025 fiscal period end).New Risk • Dec 03New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: US$8.57m This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (20% average weekly change). Market cap is less than US$10m (US$8.57m market cap).お知らせ • Aug 01Hong Kong Pharma Digital Technology Holdings Limited announced delayed 20-F filingOn 07/31/2025, Hong Kong Pharma Digital Technology Holdings Limited announced that they will be unable to file their next 20-F by the deadline required by the SEC.Valuation Update With 7 Day Price Move • Jul 31Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to US$1.08, the stock trades at a trailing P/E ratio of 6.2x. Average trailing P/E is 16x in the Logistics industry in the US.Valuation Update With 7 Day Price Move • Jul 01Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to US$1.19, the stock trades at a trailing P/E ratio of 6.9x. Average trailing P/E is 16x in the Logistics industry in the US.Valuation Update With 7 Day Price Move • Jun 03Investor sentiment improves as stock rises 32%After last week's 32% share price gain to US$1.58, the stock trades at a trailing P/E ratio of 9.1x. Average trailing P/E is 16x in the Logistics industry in the US.Valuation Update With 7 Day Price Move • May 19Investor sentiment improves as stock rises 19%After last week's 19% share price gain to US$1.29, the stock trades at a trailing P/E ratio of 7.4x. Average trailing P/E is 17x in the Logistics industry in the US.Valuation Update With 7 Day Price Move • May 01Investor sentiment improves as stock rises 23%After last week's 23% share price gain to US$1.19, the stock trades at a trailing P/E ratio of 6.9x. Average trailing P/E is 16x in the Logistics industry in the US.New Risk • Apr 19New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: US$9.97m This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). High level of non-cash earnings (36% accrual ratio). Market cap is less than US$10m (US$9.97m market cap).New Risk • Apr 16New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). High level of non-cash earnings (36% accrual ratio). Minor Risk Market cap is less than US$100m (US$13.2m market cap).Valuation Update With 7 Day Price Move • Apr 14Investor sentiment improves as stock rises 17%After last week's 17% share price gain to US$1.27, the stock trades at a trailing P/E ratio of 7.3x. Average trailing P/E is 19x in the Logistics industry in the US.Reported Earnings • Mar 30First half 2025 earnings releasedFirst half 2025 results: EPS: US$0.083. Net income: US$828.6k (up US$828.6k from 1H 2024).Valuation Update With 7 Day Price Move • Mar 24Investor sentiment improves as stock rises 25%After last week's 25% share price gain to US$1.36, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 20x in the Logistics industry in the US.Valuation Update With 7 Day Price Move • Mar 07Investor sentiment deteriorates as stock falls 23%After last week's 23% share price decline to US$1.36, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 21x in the Logistics industry in the US.Valuation Update With 7 Day Price Move • Feb 13Investor sentiment improves as stock rises 21%After last week's 21% share price gain to US$2.20, the stock trades at a trailing P/E ratio of 18.2x. Average trailing P/E is 22x in the Logistics industry in the US.Valuation Update With 7 Day Price Move • Jan 30Investor sentiment deteriorates as stock falls 23%After last week's 23% share price decline to US$2.17, the stock trades at a trailing P/E ratio of 17.9x. Average trailing P/E is 24x in the Logistics industry in the US. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Cellyan Biotechnology は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測NasdaqCM:HKPD - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数9/30/202516-1-10N/A6/30/202518000N/A3/31/202520001N/A12/31/202421101N/A9/30/202421200N/A6/30/202419200N/A3/31/202417100N/A3/31/202313122N/Aアナリストによる今後の成長予測収入対貯蓄率: HKPDの予測収益成長が 貯蓄率 ( 3.5% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: HKPDの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: HKPDの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: HKPDの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: HKPDの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: HKPDの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YTransportation 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/26 18:44終値2026/05/22 00:00収益2025/09/30年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Cellyan Biotechnology Co., Ltd 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
New Risk • Apr 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 21% over the past year. Shareholders have been substantially diluted in the past year (114% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (US$16.3m market cap).
New Risk • Mar 29New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 114% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 21% over the past year. Shareholders have been substantially diluted in the past year (114% increase in shares outstanding). Minor Risk Market cap is less than US$100m (US$16.0m market cap).
New Risk • Mar 19New major risk - Revenue and earnings growthRevenue has declined by 21% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 21% over the past year. Market cap is less than US$10m (US$7.25m market cap).
New Risk • Mar 02New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (US$7.26m market cap). Minor Risk Latest financial reports are more than 6 months old (reported March 2025 fiscal period end).
New Risk • Dec 03New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: US$8.57m This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (20% average weekly change). Market cap is less than US$10m (US$8.57m market cap).
お知らせ • Aug 01Hong Kong Pharma Digital Technology Holdings Limited announced delayed 20-F filingOn 07/31/2025, Hong Kong Pharma Digital Technology Holdings Limited announced that they will be unable to file their next 20-F by the deadline required by the SEC.
Valuation Update With 7 Day Price Move • Jul 31Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to US$1.08, the stock trades at a trailing P/E ratio of 6.2x. Average trailing P/E is 16x in the Logistics industry in the US.
Valuation Update With 7 Day Price Move • Jul 01Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to US$1.19, the stock trades at a trailing P/E ratio of 6.9x. Average trailing P/E is 16x in the Logistics industry in the US.
Valuation Update With 7 Day Price Move • Jun 03Investor sentiment improves as stock rises 32%After last week's 32% share price gain to US$1.58, the stock trades at a trailing P/E ratio of 9.1x. Average trailing P/E is 16x in the Logistics industry in the US.
Valuation Update With 7 Day Price Move • May 19Investor sentiment improves as stock rises 19%After last week's 19% share price gain to US$1.29, the stock trades at a trailing P/E ratio of 7.4x. Average trailing P/E is 17x in the Logistics industry in the US.
Valuation Update With 7 Day Price Move • May 01Investor sentiment improves as stock rises 23%After last week's 23% share price gain to US$1.19, the stock trades at a trailing P/E ratio of 6.9x. Average trailing P/E is 16x in the Logistics industry in the US.
New Risk • Apr 19New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: US$9.97m This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). High level of non-cash earnings (36% accrual ratio). Market cap is less than US$10m (US$9.97m market cap).
New Risk • Apr 16New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). High level of non-cash earnings (36% accrual ratio). Minor Risk Market cap is less than US$100m (US$13.2m market cap).
Valuation Update With 7 Day Price Move • Apr 14Investor sentiment improves as stock rises 17%After last week's 17% share price gain to US$1.27, the stock trades at a trailing P/E ratio of 7.3x. Average trailing P/E is 19x in the Logistics industry in the US.
Reported Earnings • Mar 30First half 2025 earnings releasedFirst half 2025 results: EPS: US$0.083. Net income: US$828.6k (up US$828.6k from 1H 2024).
Valuation Update With 7 Day Price Move • Mar 24Investor sentiment improves as stock rises 25%After last week's 25% share price gain to US$1.36, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 20x in the Logistics industry in the US.
Valuation Update With 7 Day Price Move • Mar 07Investor sentiment deteriorates as stock falls 23%After last week's 23% share price decline to US$1.36, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 21x in the Logistics industry in the US.
Valuation Update With 7 Day Price Move • Feb 13Investor sentiment improves as stock rises 21%After last week's 21% share price gain to US$2.20, the stock trades at a trailing P/E ratio of 18.2x. Average trailing P/E is 22x in the Logistics industry in the US.
Valuation Update With 7 Day Price Move • Jan 30Investor sentiment deteriorates as stock falls 23%After last week's 23% share price decline to US$2.17, the stock trades at a trailing P/E ratio of 17.9x. Average trailing P/E is 24x in the Logistics industry in the US.